Navigation Links
Pfizer Commences Its Advertising for Celebrex with All the Warnings

Pfizer manufactures Celebrex and in 2004 the sales of Celebrex was $3.3 billion worldwide. But after widespread concerns about the drug causing heart attacks the company stopped advertising//. But 16 months later the has returned to the consumer ad market in hopes of reviving sales of the drug, which plunged last year during the ad moratorium. Now the new ads feature mixed reactions of warning and also had ingredients that could boost it sales. Each ad includes a boldface warning about the drugs increased chance of inducing a heart attack or stroke that can lead to death.

Dr. Sidney Wolfe, a frequent critic of drug makers said that there is no evidence of any unique benefit with this drug but has a unique risk factor associated with it. Pfizer stopped advertising Celebrex after Merck stopped selling Vioxx, because of its heart dangers. But federal regulators ordered Pfizer to put a so-called black-box warning on Celebrex, detailing its risks and continue selling the drug. Andrew McCormick, a Pfizer spokesman said that all painkillers carry some risk and that the ads disclose Celebrex's potential dangers. Celebrex is far more expensive than the older painkillers, costing about $3 a pill.


'"/>




Page: 1

Related medicine news :

1. Pfizer unveils anti-smoking drug
2. The Effectiveness Of The Breast Cancer Drug By Pfizer
3. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
4. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
5. Pfizer’s Eraxis Approved By The FD
6. Pfizer Launches Viagra For Lung Disease In UK
7. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
8. FDA Approves Pfizer’s Anti-smoking Dru
9. Pfizer vouches safety of long-term inhaled insulin.
10. NICE Setback Rules for Pfizers Inhaled Insulin
11. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... Florida ... Florida Hospital West Florida Region. McGuinness brings experience in executive leadership and clinical ... physicians and leaders. , In her new role, that officially begins December 12, ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... teaming up on new songs with prolific Songwriter-Producer Corey “Chorus” Gibson who has ... Rowland, Ciara, Brandy…just to name a few.     https://twitter.com/coreychorus , The sessions ...
(Date:12/5/2016)... ... December 05, 2016 , ... The new knee compression sleeves come as a ... knee sleeves for lifting and any sport that requires knee compression or ... aspects to provide a higher quality knee sleeve performance. Firstly it is made out ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging Medicine ... Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, speakers, ...
(Date:12/4/2016)... (PRWEB) , ... December 02, 2016 , ... ... will give patients better access to nutraceuticals and help doctors more efficiently manage ... patient portal and practice management software platform for Integrative and Functional Medicine. ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... According to a new market research report ... Factor Technology, Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by ... projected to reach USD 779.8 Million by 2021 from USD 414.6 ... forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
(Date:12/5/2016)... and PUNE, India , December 5, 2016 /PRNewswire/ ... titled, "Surgical Sutures Market by Product Type and by Application - Global Opportunity ... for $3,360 million in 2015, and is expected to reach $5,255 million by ... segment dominated the market in 2015 with more than four-fifths share. ... ...
Breaking Medicine Technology: